1900
R.-V. Nguyen, C.-J. Li
LETTER
DeHaven, R. N.; Conway-James, N.; Koblish, M.; Little, P.
J.; DeHaven-Hudkins, D. L.; Dolle, R. E. Bioorg. Med.
Chem. 2005, 15, 5114. (c) Shi, G. Q.; Drpinski, J. F.; Zhang,
Y.; Santini, C.; Sahoo, S. P.; Berger, J. P.; MacNaul, K. L.;
Zhou, G.; Agrawal, A.; Alvaro, R.; Cai, T.; Hernandez, M.;
Wright, S. D.; Moller, D. E.; Heck, J. V.; Meinke, P. T.
J. Med. Chem. 2005, 48, 5589.
SiO2 (gradient eluent: hexane–EtOAc = 10:1 to 1:1) to give
241 mg (44% yield) of product (Table 2, entry 6).
(17) Typical Experimental Procedure for the Ag-Catalyzed
Coupling of Aldehyde, Amine, and Alkyne under
Normal Heating Conditions
Salicylaldehyde (209 mL, 2 mmol), morpholine (348 mL, 4
mmol), 2-methyl-3-butyn-2-ol (387 mL, 4 mmol), and AgCl
(14.3 mg, 0.10 mmol) were mixed in a reaction flask at 80 °C
in a oil bath in MeCN overnight. The solvent was removed
under reduced pressure, and the crude mixture was isolated
via column chromatography on SiO2 (gradient eluent:
hexane–EtOAc = 10:1 to 1:1) to give 220 mg (44% yield) of
product (Table 2, entry 6).
(2) Jimenez, M. C.; Miranda, M. A.; Tormos, R. J. Org. Chem.
1998, 63, 1323.
(3) Bartoli, G.; Bosco, M.; Caretti, D.; Dalpozzo, R.; Todesco,
P. E. J. Org. Chem. 1987, 52, 4381.
(4) (a) Bertolini, F.; Crotti, P.; Di Bussolo, V.; Macchia, F.;
Pineschi, M. J. Org. Chem. 2007, 72, 7761. (b) Kuethe, J.
T.; Wang, A.; Journet, M.; Davies, I. W. J. Org. Chem. 2005,
70, 3727.
(18) 2-Methyl-1-(3-piperidin-1-yl-3H-benzofuran-2-
ylidene)propan-2-ol (Table 2, Entry 1)
(5) Nakamura, I.; Yamamoto, Y. Chem. Rev. 2004, 104, 2127.
(6) For a recent example, see: Szlosek-Pinaud, M.; Diaz, P.;
Martinez, J.; Lamaty, F. Tetrahedron 2007, 63, 3340.
(7) (a) Tietze, L. F.; Ila, H.; Bell, H. P. Chem. Rev. 2004, 104,
3453. (b) Shibasaki, M.; Vogl, E. M.; Ohshima, T. Adv.
Synth. Catal. 2004, 346, 1533.
(8) Nguyen, R. V.; Yao, X.; Li, C. J. Org. Lett. 2006, 8, 2397.
(9) For recent examples of A3-coupling, see: (a) Sreedhar, B.;
Reddy, P. S.; Krishna, C. S. V.; Babu, P. V. Tetrahedron
Lett. 2007, 48, 7882. (b) Kidwai, M.; Bansal, V.; Mishra, N.
K.; Kumar, A.; Mozumdar, S. Synlett 2007, 1581. (c) Li, P.;
Wang, L. Tetrahedron 2007, 63, 5455. (d) Gommermann,
N.; Knochel, P. Chem. Eur. J. 2006, 12, 4380. (e) Wei, C.;
Mague, J. T.; Li, C. J. Proc. Natl. Acad. Sci. U.S.A. 2004,
101, 5749. For a review of the A3-coupling see: (f) Wei,
C.; Li, Z.; Li, C. J. Synlett 2004, 1472.
IR (neat): 3419 (br), 2933, 1696, 1463, 1158 cm–1. 1H NMR
(400 MHz, CDCl3): d = 7.36 (m, 1 H), 7.24 (m, 1 H), 6.99
(m, 1 H) 5.13 (s, 1 H), 4.79 (s, 1 H), 2.58 (m, 2 H), 2.40 (m,
2 H), 1.53–1.39 (m, 12 H) ppm. 13C NMR (75 MHz, CDCl3):
d = 157.7, 152.2, 129.5, 126.3, 125.4, 122.2, 113.8, 109.9,
70.6, 67.8, 49.6, 30.9, 30.8, 26.5, 24.6 ppm. MS (EI): m/z
(%) = 223 [M+], 214, 189. HRMS: m/z calcd for C17H23O2N:
273.1729; found: 273.17.
1-(3-Piperidin-1-yl-3H-benzofuran-2-ylidenemethyl)-
cyclohexanol (Table 2, Entry 2)
IR (neat): 3419 (br), 2948, 1698, 1612, 1464, 1289 cm–1. 1H
NMR (400 MHz, CDCl3): d = 7.33 (m, 1 H), 7.17 (m, 1 H),
6.91 (m, 1 H), 6.85 (m, 1 H), 5.08 (s, 1 H), 4.74 (s, 1 H), 2.53
(m, 2 H), 2.32 (m, 2 H), 1.85–1.36 (m, 16 H) ppm. 13C NMR
(100 MHz, CDCl3): d = 157.6, 152.9, 129.4, 126.2, 125.2,
122.1, 112.4, 109.9, 71.7, 67.8, 49.6, 30.0, 26.5, 25.8, 24.6,
23.0 ppm. MS (EI): m/z (%) = 313 [M+], 229, 214. HRMS:
m/z calcd for C20H27O2N: 313.2036; found: 313.2042.
N-[1-Ethyl-1-(3-piperidin-1-yl-3H-benzofuran-2-
ylidenemethyl)propyl]-4-methylbenzenesulfonamide
(Table 2, Entry 3)
(10) Patil, N. T.; Wu, H.; Yamamoto, Y. J. Org. Chem. 2005, 70,
4531.
(11) Ukhin, L. Y.; Komissarov, V. N.; Lendeman, S. V.;
Khrustalyov, V. N.; Struchkov, Y. T. Chem. Heterocycl.
Compd. 2002, 38, 1174.
(12) (a) Yan, B.; Liu, Y. Org. Lett. 2007, 9, 4323. (b) Kidwai,
M.; Bansal, V.; Kumar, A.; Mozumdar, S. Green Chem.
2007, 9, 742. (c) Lo, V. K. Y.; Liu, Y.; Wong, M. K.; Che,
C. M. Org. Lett. 2006, 8, 1529. (d) Wei, C.; Li, C. J. J. Am.
Chem. Soc. 2003, 125, 9584.
(13) (a) Reddy, K. M.; Babu, N. S.; Suryanarayana, I.; Sai Prasad,
P. S.; Lingaiah, N. Tetrahedron Lett. 2006, 47, 7563.
(b) Yan, W.; Wang, R.; Xu, Z.; Xu, J.; Lin, L.; Shen, Z.;
Zhou, Y. J. Mol. Catal. A: Chem. 2006, 255, 81. (c) Li, Z.;
Wei, C.; Chen, L.; Varma, R. S.; Li, C. J. Tetrahedron Lett.
2004, 45, 2443. (d) Wei, C.; Li, Z.; Li, C. J. Org. Lett. 2003,
5, 4473.
IR (neat): 2970, 2802, 1696, 1612, 1594, 1461, 1157, 1094
cm–1. 1H NMR (400 MHz, CDCl3): d = 7.64 (m, 2 H), 7.25
(m, 2 H), 6.92 (m, 2 H), 6.92 (m, 4 H), 5.26 (s, 1 H), 4.53 (s,
1 H), 4.19 (s, 1 H), 2.39 (m, 1 H), 2.27 (m, 1 H), 2.19 (s, 3
H), 2.03 (m, 3 H), 1.74 (m, 3 H), 1.34 (m, 6 H), 0.84 (m, 6
H) ppm. 13C NMR (75 MHz, CDCl3): d = 157.5, 153.6,
142.5, 139.9, 129.6, 129.0, 127.4, 126.0, 125.3, 122.2,
110.0, 108.0, 67.8, 62.7, 49.6, 30.3, 26.3, 24.5, 21.6, 8.4
ppm. MS (EI): m/z (%) = 454 [M+], 283, 214, 155. HRMS:
m/z calcd for C26H34O3N2S: 454.2290; found: 454.2282.
4-(3-Piperidin-1-yl-3H-benzofuran-2-ylidene)butan-2-ol
(Table 2, Entry 4)
(14) For microwave-promoted A3-coupling, see: (a) Ju, Y.; Li,
C. J.; Varma, R. S. QSAR Comb. Sci. 2004, 23, 891.
(b) Shi, L.; Tu, Y. Q.; Wang, M.; Zhang, F. M.; Fan, C. A.
Org. Lett. 2004, 6, 1001.
(15) (a) Harkat, H.; Blanc, A.; Weibel, J. M.; Pale, P. J. Org.
Chem. 2008, 73, 1620. (b) Liu, Y.; Song, F.; Song, Z.; Liu,
M.; Yan, B. Org. Lett. 2005, 7, 5409. (c) Chaudhuri, G.;
Kundu, N. G. J. Chem. Soc., Perkin Trans. 1 2000, 775.
(d) Gabriele, B.; Salerno, G.; Lauria, E. J. Org. Chem. 1999,
64, 7687.
IR (neat): 3382 (br), 2931, 1701, 1612, 1475, 1218, 1151
cm–1. 1H NMR (400 MHz, CDCl3): d = 7.36 (m, 1 H), 7.20
(m, 1 H), 6.94 (m, 1 H), 6.80 (m, 1 H), 4.96 (m, 1 H), 4.78
(s, 1 H), 3.93 (sept, 1 H, J = 6.0 Hz), 2.39 (m, 6 H), 1.53–
1.38 (m, 9 H) ppm. 13C NMR (75 MHz, CDCl3): d = 158.1,
154.9, 129.5, 126.4, 125.9, 121.7, 109.8, 101.7, 68.1, 67.2,
49.6, 35.4, 26.4, 24.6, 23.1 ppm. MS (EI): m/z (%) = 273
[M+], 214, 188. HRMS: m/z calcd for C17H23O2N: 273.1729;
found: 273.1723.
5-(3-Diethylamino-3H-benzofuran-2-ylidene)pentan-1-
(16) Typical Experimental Procedure for the Cu-Catalyzed
Coupling of Aldehyde, Amine, and Alkyne under
Microwave Irradiation
ol (Table 2, Entry 5)
IR (neat): 3412 (br), 2935, 1711, 1611, 1463, 1234 cm–1. 1H
NMR (400 MHz, CDCl3): d = 7.27 (m, 1 H), 7.11 (m, 1 H),
6.84 (m, 1 H), 6.74 (m, 1 H), 4.78 (t, 1 H, J = 6.4 Hz), 4.62
(s, 1 H), 3.46 (m, 2 H), 2.45–2.17 (m, 4 H), 1.56–1.26 (m, 12
H) ppm. 13C NMR (75 MHz, CDCl3): d = 158.2, 152.6,
129.4, 126.4, 125.7, 121.5, 109.5, 66.8, 61.9, 49.2, 35.3,
32.0, 29.8, 25.3, 20.1 ppm. MS (EI): m/z (%) = 287 [M+],
214, 202. HRMS: m/z calcd for C18H25O2N: 287.1872;
In a 5 mL Biotage microwave vial, salicylaldehyde (209 mL,
2 mmol), morpholine (348 mL, 4 mmol), 2-methyl-3-butyn-
2-ol (387 mL, 4 mmol), and CuI (19 mg, 0.10 mmol) were
mixed. The vial was then capped and was subjected to
microwave irradiation for 30 min at 130 °C. The crude
mixture was directly isolated via column chromatography on
Synlett 2008, No. 12, 1897–1901 © Thieme Stuttgart · New York